共 28 条
[1]
Selvin B.L., Systemic effects of topical ophthalmic medication, In Clinical ophthalmic pharmacology, pp. 463-482, (1987)
[2]
Salminen L., Huupponen R., Systemic effects of ocular drugs.Adverse Drug React, Acute Poisoning Rev, 8, (1989)
[3]
Urtti A., Salminen L., Miinalainen O., Systemic absorption of ocular pilocarpine is modified by polymer matrices, Int. J. Pharm, 23, (1985)
[4]
Lee V.H.L., Robinson J.R., Review: Topical ocular drug delivery: Recent developments and future challenges, J. Ocul. Pharm, 2, (1986)
[5]
Duke-Elder S., System of ophthalmology, The foundations of ophthalmology: Heredity,pathology,diagnosis and therapeutics, VII, (1962)
[6]
Salminen L., Pakarinen P., Is the drop size of ophthalmic preparations equal and ideal, Fifth International Congress of Eye Research, (1982)
[7]
Lederer C.M., Harold R.E., Drop size of commercial glaucoma medication, Amer. J.Qphthalmol, 101, (1986)
[8]
Kass M.A., Hodapp E., Gordon M., Kolker A.E., Goldberg I., Part I. Patient administration of eyedrops: Interview, Ann. Ophthalmol, 14, (1982)
[9]
Kass M.A., Hodapp E., Gordon M., Kolker A.E., Goldberg I., Patient administration of eyedrops: Observation, Ann. Ophthalmol, 14, (1982)
[10]
Trueblood J.H., Rossomondo R.M., Carlton W.H., Wilson L.A., Corneal contact times of ophthalmic vehicles, Arch. Ophthalmol, 93, (1975)

